Challenging the paradigm: moving from umbrella labels to treatable traits in airway disease

Andrew Bush, Ian D. Pavord

Source: Breathe, 17 (3) 210053; 10.1183/20734735.0053-2021
Journal Issue: September

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Andrew Bush, Ian D. Pavord. Challenging the paradigm: moving from umbrella labels to treatable traits in airway disease. Breathe, 17 (3) 210053; 10.1183/20734735.0053-2021

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Z-alpha1-antitrypsin polymers and small airways disease: a new paradigm in COPD development?
Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases
Year: 2020

The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions
Source: Eur Respir J, 52 (3) 1800328; 10.1183/13993003.00328-2018
Year: 2018

A label-free approach to airways disease: phenotypes, endotypes and treatable traits
Source: ERS Research Seminar 2017 – Precision medicine in airway diseases
Year: 2017

Treatable traits: toward precision medicine of chronic airway diseases
Source: Eur Respir J 2016; 47: 410-419
Year: 2016

The role of cluster analysis in defining phenotypes of obstructive airway diseases: is there a need for a new taxonomy of obstructive airway diseases?
Source: Annual Congress 2011 - PG11 Update of phenotypes of asthma and COPD
Year: 2011

Th-2 signature in chronic airway diseases: towards the extinction of asthma-COPD overlap syndrome?
Source: Eur Respir J, 49 (5) 1602397; 10.1183/13993003.02397-2016
Year: 2017

Asthma and chronic obstructive pulmonary disease training in an online environment: a new response to a growing problem
Source: International Congress 2019 – Nursing care across the spectrum of respiratory illnesses
Year: 2019

Rethinking the way we are treating established airway disease: current guidelines need to change 
Source: International Congress 2016 – Presentation and discussion of a draft Lancet Commission on Asthma
Year: 2016

Interstitial lung disease: new challenges and evolving phenotypes
Source: Eur Respir Rev 2009; 19: 91-93
Year: 2010

Disturbed sleep and breathing disturbances in COPD and restrictive lung diseases: evidence gaps and challenges in diagnosis and treatment
Source: 5th Sleep and Breathing Conference
Year: 2019

Presentation by an expert: Emerging relationships between airway microbiota and chronic respiratory disease : mechanisms of disease onset
Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease
Year: 2013

NOVELTY: a landmark study in phenotyping and endotyping chronic obstructive airway diseases in real clinical practice
Source: Eur Respir J, 58 (3) 2100627; 10.1183/13993003.00627-2021
Year: 2021

Mucosal cryobiopsies: A novel method for studying obstructive airways disease?
Source: International Congress 2017 – Innovation in COPD: techniques and facts
Year: 2017

What are the common biological mechanisms that lead to obstructive airway disease?
Source: International Congress 2016 – Early life origins of asthma and COPD
Year: 2016

Improving adherence in chronic airways disease: are we doing it wrongly?
Source: Breathe, 17 (2) 210022; 10.1183/20734735.0022-2021
Year: 2021

Treatment of severe stable COPD: the multidimensional approach of treatable traits
Source: ERJ Open Res, 6 (3) 00322-2019; 10.1183/23120541.00322-2019
Year: 2020